stella
beta
The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland — Stella
Recruiting
Back to Kidney Failure trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Trial locations
(1 site)
Finland
Helsinki University Hospital, Helsinki
View full record on ClinicalTrials.gov